Aptamers: active targeting ligands for cancer diagnosis and therapy
about
Synthetic biology for pharmaceutical drug discoveryGold nanoparticles for cancer radiotherapy: a reviewDevelopment of Cell-SELEX Technology and Its Application in Cancer Diagnosis and TherapyEdible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer TherapyA Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal AdenocarcinomaAn 'activatable' aptamer-based fluorescence probe for the detection of HepG2 cells.Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein BiomarkersConstruction and optimization of an efficient amplification method of a random ssDNA library by asymmetric emulsion PCRPrediction of aptamer-protein interacting pairs using an ensemble classifier in combination with various protein sequence attributesRaman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis.Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.Polymeric oncolytic adenovirus for cancer gene therapy.Rapid Complexation of Aptamers by Their Specific Antidotes.Application of aptamers in diagnostics, drug-delivery and imaging.Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.Status and Prospects of Aptamers as Drug Components.A Highlight of Recent Advances in Aptamer Technology and Its Application.Protocol: MYTHBUSTERS: a universal procedure for sample preparation for mass spectrometry.Surface engineering of macrophages with nucleic acid aptamers for the capture of circulating tumor cells.Surface functionalization of polymeric nanoparticles for tumor drug delivery: approaches and challenges.Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy.Novel biotechnology approaches in colorectal cancer diagnosis and therapy.Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance. Part 2: Treatment.Biomolecular engineering for nanobio/bionanotechnology.Characterization of the specific interaction between the DNA aptamer sgc8c and protein tyrosine kinase-7 receptors at the surface of T-cells by biosensing AFM.Current Advances in Aptamers for Cancer Diagnosis and Therapy.Anti-MUC1 aptamer: A potential opportunity for cancer treatment.A surface plasmon field-enhanced fluorescence reversible split aptamer biosensor.Molecular modeling and SPRi investigations of interleukin 6 (IL6) protein and DNA aptamers.Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects.
P2860
Q26775582-A67F65BB-EB78-4507-A487-F01F545963E4Q28066413-F8C900E4-F366-4BF9-9001-EE2337C828A8Q28080168-94E55433-1403-4BB5-9753-F938549FFB2AQ28394225-6C214B0D-5260-43DF-A3A7-3F81A8E95884Q30275702-CDB95B0E-3241-465E-8C86-B37C6BE5A86EQ33674521-23009BB6-BB1E-4B2C-B93F-2CFCACE612F3Q33832781-B78CC3E6-52A6-403B-A8A3-F711FE7A3CB8Q35869622-D9B5D3E6-D7CE-4D80-AA8A-6F001772CC43Q36034999-8B499024-F4EA-4C39-95F1-7CD89BAFC586Q36298664-EE96CAA6-F838-4446-B1A2-597D1B586ABFQ36333938-CBC549FA-CA60-4C51-9EC2-4B17262639A8Q36344901-C33510FB-31F7-4AF2-9548-27DBD0EEC320Q38287977-1D67DDFC-D59A-44D3-BD77-8886E8192AA1Q38291061-51416ED3-724A-47A7-BAB4-CF93DF65ED5EQ38291786-671D6D63-A452-44DC-A8D0-0893C173E6B5Q38488502-2A9915F7-0E77-4B05-B2A3-1F5018F1B70FQ38541697-3C80A342-9D0C-4434-8D68-9867EF1578B7Q38729166-D6F611EC-45D6-4FD3-984E-43BC03229E2CQ38827820-E04C3533-B4E1-4052-8C89-62EE0241792CQ38899902-ED1BABDF-A7EE-4D2C-8522-F77BAADE5315Q38976861-9F5B781B-FF22-4C6F-95CB-F81D5F562F35Q39151211-26CF065F-3BB8-4062-9136-895A304DD204Q39180555-7CCD8886-B590-4322-B31E-C013EC9889C9Q39297215-0A570CD9-4238-41E4-A690-FF5AD3B326EBQ41834826-E871FEB9-92B1-49AD-AC9E-A80476DF33DCQ47561686-E0C30FFB-4A0B-4778-A253-3F09373E07F8Q48009199-115A8654-9F55-4330-9EE0-4580F3440DF8Q50519843-5D48D7B7-CFC1-42E2-8366-A6DD6BE3A96EQ50954695-8E57F892-773F-4A13-BE57-8B09E608E9A8Q55018323-440E3F90-F6AE-4166-B843-3E6440BD9734Q55518839-33406C48-239E-45FD-80E7-8EAA21A92610
P2860
Aptamers: active targeting ligands for cancer diagnosis and therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Aptamers: active targeting ligands for cancer diagnosis and therapy
@ast
Aptamers: active targeting ligands for cancer diagnosis and therapy
@en
type
label
Aptamers: active targeting ligands for cancer diagnosis and therapy
@ast
Aptamers: active targeting ligands for cancer diagnosis and therapy
@en
prefLabel
Aptamers: active targeting ligands for cancer diagnosis and therapy
@ast
Aptamers: active targeting ligands for cancer diagnosis and therapy
@en
P2093
P2860
P921
P356
P1433
P1476
Aptamers: active targeting ligands for cancer diagnosis and therapy
@en
P2093
P2860
P304
P356
10.7150/THNO.10257
P5008
P577
2015-01-20T00:00:00Z